Parasternal Blockade and Serum Lactate in Cardiac Surgery
Recruiting
N/A
Interventional Study
Elective Cardiac Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 86 (estimated)
- Sponsor
- Instituto Mexicano del Seguro Social · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and ser…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients older than 18 years
* Either sex
* ASA II-III
* Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.
Exclusion Criteria:
* Patients with pre-existing conditions that could independently affect serum lactate levels.
Contacts